Researchers identify a new mode of drug resistance to emerging therapies in prostate cancer
11/18/2015
Discovery ultimately may help predict which patients might benefit most from treatment.Advanced prostate cancer is a disease notoriously resistant to treatment.
Many hands make light work and improve health, researchers have found
11/18/2015
Getting help with baby care could keep families healthier and extend their lives, according to a new study into bird behaviour.
Cancer risk for smokeless tobacco users
11/18/2015
Research has shown that users of exclusively smokeless tobacco have higher exposure to some tobacco constituents, including one carcinogenic substance, than smokers.
FDA approves Darzalex for patients with previously treated multiple myeloma
11/17/2015
The U.S. Food and Drug Administration has granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments.
Nondrug interventions improve quality of life for Chinese cancer patients
11/17/2015
A meta-analysis of dozens of studies of traditional Chinese medicine and other nonpharmacological interventions meant to improve patients' quality of life affirms that these approaches, on the whole...
Research points to why some colorectal cancers recur after treatment
11/17/2015
Cetuximab, marketed as Erbitux®, is one of the key therapies for metastatic colorectal cancer. Yet the cancer still returns in some patients, shortening overall survival.
Group Health's lifesaving approach to screening for colon cancer steps forward
11/17/2015
Research shows innovative approach serves health care consumers over long term.
Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
11/17/2015
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
11/17/2015
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Published research reports lung cancer CTC enrichment using Parsortix
11/17/2015
ANGLE plc, the specialist medtech company, is delighted to announce that Cancer Research UK Manchester Institute has published highly encouraging results from its work in lung cancer patients using...